Rheumatoid arthritis: S100A9 does not predict response to etanercept

Nature Reviews Rheumatology 13, 130 (2017). doi:10.1038/nrrheum.2017.13 Author: Joanna Collison Pretreatment serum levels of protein S100A9 in a UK cohort of 236 patients with RA did not correlate with EULAR response to etanercept, despite promising results from a previous small-scale study. Levels of S100A9 were not associated with moderate response (P = 0.957

http://feeds.nature.com/~r/nrrheum/rss/current/~3/gFnunWKajC0/nrrheum.2017.13

Source: Nature Reviews Rheumatology - February 1, 2017 Category: Rheumatology Authors: Joanna Collison Tags: Research Highlight Source Type: research

More News: Arthritis | Enbrel | Rheumatoid Arthritis | Rheumatology | Study